Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone and Two Doses of Misoprostol for Medical Abortion at 71-84 Days
NCT05119439Phase 4Terminated
- Sponsor
- Gynuity Health Projects
- Start
- Oct 2022
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of mifepristone, misoprostol in pregnancy, sponsored by Gynuity Health Projects. Started Oct 2022; status: terminated.
02
Drugs
mifepristonemisoprostol
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT05119439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05119439.